AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-34119828_ITM" title="Facts and information about Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response.">Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response.</a>

Close Set up an RSS feed that alerts you when new articles from PR Newswire are available.

Frequently asked questions about RSS feeds

Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response.

PR Newswire

| March 07, 2008 | COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Abbott's FISH Technology Provides Analytical Tool with Potential to Assess Clinical Response to Lung Cancer Treatment in Patients with Non-Small-Cell Lung Cancer

DES PLAINES, Ill., March 7 /PRNewswire-FirstCall/ -- Abbott today announced that its molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals, Inc. to develop a gene test to potentially assess the clinical benefit of Tarceva(R) (erlotinib), an oral tablet indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.

…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Digilab Inc. Reaches Milestone in Biomarker Study in Lung Cancer for Abbott.: Press release article from: Business Wire December 19, 2006 700+ words
...Peptidomics collaboration with Abbott Molecular. In the first phase...identified candidate biomarkers for lung cancer using its proprietary Peptidomics...DPD) technology platform. Abbott has exercised its right to...candidate markers for further use. Abbott has the option to acquire an...


Digilab Inc reaches milestone in biomarker study in lung cancer for Abbott.: News wire article from: Chemical Business Newsbase December 19, 2006 700+ words
...Peptidomics collaboration with Abbott Molecular (Abbott). In the first phase of the...identified candidate biomarkers for lung cancer using its proprietary Peptidomics...DPD) technology platform. Abbott has exercised its right to evaluate...


Caprion pairs lung cancer work with Abbott.(Thursday, February 5)(Brief Article): Newspaper article from: BioWorld Week February 9, 2004 700+ words
...proteomics platform in a lung cancer drug discovery collaboration with Abbott Laboratories. The companies...therapeutics for the disease. Abbott Park, Ill-based Abbott will nonexclusively...for non-small-cell lung cancer. "We see this as an...


Abbott to develop lung cancer test with ALSI.(Abbott Laboratories )(Advanced...: Newspaper article from: Pharma Marketletter May 22, 2006 700+ words
...health care major Abbott Laboratories has...monitoring small-cell lung cancer, an aggressive...studies as a test for lung cancer, which accounts...13% of the new lung cancer cases in the USA...development, at Abbott. Under terms of...


Abbott Northwestern Hospital's Virginia Piper Cancer Institute Announces The...: Press release article from: PR Newswire August 26, 2003 700+ words
...services related to lung cancer diagnosis and treatment for patients at Abbott Northwestern Hospital...specialties on the Abbott Northwestern campus...involved in the care of lung cancer patients including...Cancer Institute." Abbott Northwestern's...Institute offers ...


Abbott enters agreement with Advanced Life Science Institute to develop lung...: News wire article from: Chemical Business Newsbase May 16, 2006 700+ words
...NewsBase - Press Release) Abbott has entered into a licensing...and monitoring small cell lung cancer. Currently, no diagnostic...US for testing serum for lung cancer. Under terms of the agreement, Abbott obtains worldwide rights...


Abbott Northwestern Hospital's Virginia Piper Cancer Institute Offers...: Press release article from: Business Wire October 25, 2005 700+ words
...program, Living with Lung Cancer, will be a free...Building on the Abbott Northwestern campus...services related to lung cancer diagnosis and treatment...for patients at Abbott Northwestern Hospital...about the Piper Lung Cancer Program is available...


BioVisioN AG, of Hanover, Germany, signed an agreement with Abbott...: Newspaper article from: BioWorld International September 14, 2005 700+ words
...Germany, signed an agreement with Abbott Laboratories, of Abbott Park, Ill., to collaborate on the discovery of biomarkers for lung cancer. BioVisioN will analyze biological samples provided by Abbott to discover tumor biomarkers...


Abbott licenses ALSI biomarker to develop lung cancer test.(Advanced Life...: Magazine article from: Medical Device Week May 19, 2006 700+ words
Abbott licenses ALSI biomarker to develop lung cancer test By KAREN YOUNG...Daily Staff Writer Abbott (Abbott Park, Illinois...how small-cell-lung cancer is diagnosed and managed...By partnering with Abbott, ALSI may be able...


Abbott licenses ALSI biomarker to develop lung cancer test.: Magazine article from: Diagnostic Update May 25, 2006 700+ words
Abbott licenses ALSI biomarker to develop lung cancer test By KAREN...small-cell-lung cancer is diagnosed...partnering with Abbott, ALSI may be...tomography (CT). Abbott said that according...Atlanta), lung cancer is the leading...

For more facts and information, see all results

Source: HighBeam Research, Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test...

The AccessMyLibrary advertising network includes: